查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830610

草藥市場（按形態、植物來源、類型、適應症和分銷管道分類）—2025-2032 年全球預測

Herbal Medicine Market by Form, Botanical Origin, Type, Indication, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年草藥市場規模將成長至 1,193.2 億美元，複合年成長率為 9.68%。

主要市場統計數據
基準年2024年 569.4億美元
預計2025年 621.9億美元
預測年份：2032年 1193.2億美元
複合年成長率（%） 9.68%

現代草藥生態系統的權威指南，捕捉消費者需求的變化、科學檢驗趨勢和相關人員的期望

現代草藥領域正處於悠久傳統與現代快速創新的交匯點。隨著植物化學、臨床檢驗和品質保證技術的進步，消費者對天然、預防和補充性醫療保健的興趣日益成熟。因此，研究、生產、分銷和臨床實踐領域的相關人員正在重新思考植物產品的開發、定位和監管方式。

本介紹概述了影響產品系列、採購決策和商業模式的關鍵動態。它強調了證據生成、安全和可追溯系統以及數位藥房和訂閱模式等零售創新在重新定義可及性方面所發揮的作用。重要的是，將傳統藥理學與植物藥協同作用相結合的混合產品的興起，正在改變臨床醫生和消費者評估療效和風險的方式。

本節從相關人員合作的觀點，闡述了監管機構、付款人和從業人員如何日益關注標準化品質、可重複劑量和透明的供應鏈。此外，本節還概述了眼光敏銳的消費者不斷變化的期望，他們要求獲得永續性證據和檢驗的功效數據。這些因素的共同作用，為尋求在這個快速發展的領域負責任地擴展業務的組織帶來了機遇，也帶來了複雜性。

結構創新、監管加強和數位化加速的整合從根本上重塑了產品開發、採購和商業化的動態。

過去五年，草藥產業格局發生了顯著變化，從生產到病患療效都發生了變化。分析化學和基因組學的進步改進了物種鑑定和雜質檢測，使製造商能夠提供更一致、更可預測的產品。同時，數位健康平台和遠端醫療的發展降低了資訊和分銷壁壘，提高了對臨床證據和安全數據的期望，同時加速了直接面對消費者的銷售管道的發展。

監管生態系統也在同步調整，當局強調良好生產規範 (GMP)、性能記錄和不利事件報告。監管力度的加強，加上消費者對永續性的需求，正在推動與供應商建立夥伴關係關係的投資，這些供應商優先考慮可追溯的供應鏈、負責任的採收和長期的資源管理。從微膠囊萃取物到經皮凝膠，劑型和給藥系統的創新正在改變產品開發的重點，並開闢新的治療領域。

同時，商業化進程也變得更加協作，契約製造和原料專家與品牌商攜手合作，以加快產品上市速度，並助力小型創新企業實現規模化發展。這種轉變反映了更廣泛的產業成熟度，其中科學嚴謹性、數位化覆蓋率和供應鏈完整性共同決定了競爭差異化和長期生存能力。

對 2025 年美國關稅如何刺激整個價值鏈採購多樣化、營運彈性和監管合規性的投資進行現實分析。

2025年美國新關稅的實施，將對整個草藥產業的植物供應鏈、籌資策略和商業性定位產生多方面的影響。某些植物原料和成品製​​劑的進口關稅促使企業重新評估供應商組合，鼓勵採購團隊實現採購區域多元化，並與直接供應商建立更緊密的關係，以降低單一產地風險。隨著企業不斷適應新形勢，許多企業優先選擇擁有強大追溯系統和垂直整合能力的供應商，以緩解關稅引發的波動。

關稅壓力也影響配方和包裝的選擇，產品開發人員力求最佳化投入清單和包裝空間，以限制跨國成本。面對不斷上升的到岸成本，製造商採取了一系列應對措施，包括提高營運效率、調整物流路線以及選擇性地將成本轉嫁給貿易夥伴。對於某些品牌而言，這意味著將通路投資重點轉向利潤率更高的直銷管道，從而縮短促銷週期並更好地管理價格彈性。

關稅不僅加速了直接的商業性調整，也加速了策略討論，包括關鍵生產過程的本土化、區域製造能力的投資以及低關稅地區供應商發展項目的深化。這些調整正在推動從交易型採購向發展供應商生態系統的轉變，其中長期夥伴關係、技術合作以及在品質保證方面的共用對於韌性至關重要。同時，合規團隊正在增加對貿易分類專業知識和原產地檢驗的投資，以確保關稅處理得到適當應用，從而減少意外的成本流失和聲譽風險。

綜合細分洞察，將產品形態、植物來源、產品類型、治療適應症和通路動態與策略組合決策連結起來

細分市場為確定產品策略、研發重點和通路投資優先順序提供了策略視角。乳膏和軟膏、精油、液體萃取物、粉劑、糖漿、片劑和膠囊、茶劑和湯劑都需要配方、穩定性和合規性方面的考量，從而影響生產和儲存策略。除了劑型選擇外，植物來源也是決定性因素。樹皮、花朵、果實和種子、葉子和根的活性成分、採收週期和永續性限制各不相同。因此，植物的選擇不僅決定了治療目的，也決定了供應風險和可追溯性要求。

按產品類型細分，產品定位和商業化路徑也有所不同。膳食補充劑和草本機能性食品涵蓋營養和健康定位，並注重消費者信任和科學基礎。草藥需要更高水準的臨床證據和法規遵循性，這會影響開發時間表和經銷夥伴。按適應症細分，涵蓋心血管健康、消化器官系統疾病、整體健康和免疫力增強、肝腎疾病、精神健康、呼吸系統疾病、性健康和生殖問題、皮膚疾病等，指南了研發優先事項和索賠策略。

分銷管道塑造獲取途徑和品牌體驗：阿育吠陀診所和傳統治療師提供臨床信譽和文化信任，直銷利用個人網路和體驗式行銷，健康保健商店和醫院/藥房提供精心策劃的臨床接觸點，在線藥房/電商實現規模化和數據主導的精準定位，超級市場/大賣場提供廣泛的知名度和便利性。了解這些細分市場如何相互作用，可以幫助您了解植物來源的特定劑型如何與特定適應症和管道的監管要求相符，從而使您能夠最佳化產品組合，實現商業性可行性和合規性。

區域比較分析重點介紹美洲、歐洲、中東和非洲以及亞太地區的草藥產品優勢、監管差異和供應鏈影響

區域動態對整個草藥生態系統的供應鏈、監管方式和消費者偏好有著強大的影響。在美洲，成熟的零售基礎設施和消費者對循證天然健康解決方案日益成長的興趣，為優質配方和臨床導向的補充劑創造了有利條件。跨境貿易協定和關稅制度進一步影響了籌資策略，迫使企業在成本和特定植物物種的取得之間取得平衡。

歐洲、中東和非洲是一個多元化的地區，監管環境、傳統藥物的文化接受度以及生產能力水平存在差異，因此需要採取細緻入微的市場准入策略。在歐洲部分地區，強力的法律規範和消費者保護框架要求嚴格的品質系統和清晰的功效證明；而傳統醫療實踐成熟的地區則提供了替代管道，以及與傳統治療師和當地執業醫師的合作模式。

亞太地區仍然是重要的供應和創新中心，擁有豐富的植物多樣性、深厚的傳統知識體系和大規模生產。當地消費者對草藥的熟悉度支持了產品的快速普及，而對標準化萃取技術和符合GMP標準的設施的投資則提升了出口能力。在全部區域，原料禀賦和監管完善程度等比較優勢正在推動著生產地點、研發合作和通路優先排序的策略決策。

洞察競爭動態：成分專家、契約製造、數位原生品牌和專家網路如何塑造整合和差異化

競爭格局由各種能力互補的參與者組成，從成分專家和契約製造，到數位原民品牌和由從業者主導的公司。提供經過驗證的萃取物和品管服務的成分供應商已成為尋求縮短配方時間並確保活性成分一致性的品牌的策略合作夥伴。契約製造製造商和自有品牌合作夥伴使新興品牌能夠擴大規模，使他們能夠將資源集中在行銷、宣傳驗證和通路開發。

數位優先的消費品牌透過直接互動、數據主導的個人化和敏捷的產品發布實現差異化，並通常利用訂閱模式來提升終身價值。傳統的醫生和診所網路在重視文化信任和麵對面診斷的領域仍然具有影響力，並創造了將臨床檢驗與社區倡導相結合的混合商業化模式。在整個產業中，我們看到越來越多的策略聯盟和併購活動旨在整合供應鏈、獲取技術力並擴大地理覆蓋範圍。

品質保證和合規能力對競爭定位日益重要。投資可追溯性、第三方偵測和透明標籤的公司正在贏得消費者和機構投資者的信任。同時，與科學主導的組織和草藥專家的夥伴關係正在推動更穩健的臨床項目，從而提升產品合法性並擴大其在傳統醫療保健途徑中的接受度。

為高階主管提供以行動為導向的策略重點，以加強其供應商生態系統、加速證據計劃、最佳化管道並提高製造敏捷性

行業領導者應採取一系列優先行動，以平衡商業性敏捷性和長期韌性。首先，建構供應商生態系統，強調在多樣性、可追溯性和品質保證方面的共同投資，而不是依賴單一來源的採購模式。加強採購地區的實地夥伴關係關係，並投資於供應商能力建設，可減少關稅和氣候相關衝擊的影響，同時提升永續性資質。

第二，加速與目標適應症和通路相符的證據產生項目。對於消費者健康產品，真實世界證據和經過驗證的生物標記可以支持可靠的定位。第三，最佳化通路組合，將投資導向高價值接點。直接管道和透過臨床醫生分銷可以更好地控制利潤和獲取數據，從而實現更有針對性的產品迭代。

第四，透過地理多元化製造和模組化生產能力提升營運彈性，以便根據貿易和監管變化快速進行重新配置。最後，將監管和貿易分類專業知識納入商業規劃，預測跨境成本風險，並充分利用可用的優惠貿易協定。這些措施相結合，將形成一種協調一致的方案，以緩解短期衝擊並建立永續的競爭優勢。

嚴格的混合方法研究框架結合了初步訪談、文件分析、供應鏈追蹤和專家檢驗，確保了可靠且可操作的研究結果

研究途徑結合了多種混合方法，旨在確保研究的有效性、可靠性和實用性。主要研究包括結構化訪談和與不同相關人員的深入討論，這些利害關係人包括產品開發人員、供應鏈經理、法規事務專家、臨床醫生和通路合作夥伴。此外，還進行了現場審查和虛擬設施審核，以評估種植方法、加工能力和品管程序。

二次研究整合了監管文件、同行評審文獻和技術標準，以詳細描繪合規期望和不斷發展的最佳實踐。供應鏈追蹤利用原產地檢驗工具和證書審查來評估來源並識別濃縮風險。採用定性綜合方法，協調相關人員的不同觀點，突出可操作的主題，並透過內部三角測量和文件證據來確保一致性並減少偏見。

調查方法提供了訪談通訊協定、選擇標準和檢驗程序。研究結果與專家進行了反覆討論，以確保技術準確性並檢驗其戰略和營運意義。這種多層次的方法得出了基於證據的結論，可直接應用於商業性和技術決策者。

風險、韌性和機會的簡明綜合，展示了科學檢驗、可追溯性和負責任的商業化將如何決定未來的贏家

不斷發展的草藥產業既帶來機遇，也承擔責任。分析和臨床方法的進步，加上數位化分銷和日益成長的監管要求，正在提升整個價值鏈的標準。投資於透明供應鏈、健全的品質系統和可靠的證據產生的組織，將最有能力應對不斷變化的消費者偏好和日益嚴格的監管審查。

韌性取決於策略性採購多元化、選擇性在岸化和本地能力建設，以及快速調整營運以應對貿易或環境變化的能力。同樣重要的是，透過透明的溝通、第三方檢驗以及有針對性的臨床項目來建立信任，這些項目不僅能證實相關聲明，還能保障消費者安全。領導者迫切需要將商業性抱負與永續採購和科學嚴謹性相結合，以確保長期的品牌誠信和合規性。

總而言之，該行業正在從分散化走向專業化，科學檢驗、供應鏈完整性和負責任的商業化將共同決定哪些產品和公司將在未來幾年成功擴大規模。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將傳統草藥配方融入主流保健產品
  • 基於基因組和微生物組洞察的個人化草藥補充療法的興起
  • 藥用植物的永續野生採收和再生種植
  • 擴展遠端醫療平台，提供虛擬諮詢和草藥處方服務
  • 開發奈米乳液和脂質體遞送系統以提高草藥化合物的生物有效性
  • 製藥和營養補充劑公司合作標準化草藥萃取物的品質指標
  • 適應原蘑菇混合物在壓力管理和免疫支持的健康常規中越來越受歡迎

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 草藥市場（依形式）

  • 乳膏和軟膏
  • 精油
  • 液體萃取物
  • 粉末
  • 糖漿
  • 片劑和膠囊
  • 茶和涼茶

9. 草藥市場（植物來源）

  • 吠
  • 花
  • 水果和種子
  • 葉子
  • 根

第10章 草藥市場（按類型）

  • 草本美容產品/化妝品
  • 草本膳食補充劑
  • 草本機能性食品
  • 草藥

第 11 章 草藥市場（依適應症）

  • 心血管健康
  • 消化系統疾病
  • 改善整體健康和免疫力
  • 肝腎疾病
  • 心理健康
  • 呼吸系統疾病
  • 性健康和生殖問題
  • 皮膚病

第 12 章。草藥市場（按分銷管道）

  • 阿育吠陀診所和傳統治療師
  • 直銷
  • 健康與保健商店
  • 醫院和藥房
  • 網路藥局/電子商務
  • 超級市場/大賣場

第13章 草藥市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 草藥市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國草藥市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Ayush Herbs herbal products Company
    • Baidyanath Ayurved
    • Bionorica SE
    • Blackmores Limited
    • Cultivator Natural Products Pvt. Ltd.
    • DABUR Limited
    • Emami Limited
    • Gaia Herbs, Inc.
    • Herbal Hills
    • Himalaya Global Holdings Ltd.
Product Code: MRR-4331C112E07A

The Herbal Medicine Market is projected to grow by USD 119.32 billion at a CAGR of 9.68% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 56.94 billion
Estimated Year [2025] USD 62.19 billion
Forecast Year [2032] USD 119.32 billion
CAGR (%) 9.68%

An authoritative orientation to the modern herbal medicine ecosystem, capturing consumer demand shifts, scientific validation trends, and stakeholder expectations

The contemporary herbal medicine landscape sits at the intersection of centuries-old traditions and rapid modern innovation. Consumer interest in natural, preventive, and complementary healthcare options has matured alongside advances in phytochemistry, clinical validation, and quality assurance practices. As a result, stakeholders across research, manufacturing, distribution, and clinical practice are recalibrating how botanical products are developed, positioned, and regulated.

This introduction frames the critical dynamics shaping product portfolios, sourcing decisions, and commercial models. It highlights the roles of evidence generation, safety and traceability systems, and retail innovations such as digital pharmacies and subscription models that are redefining accessibility. Importantly, the rise of hybrid offerings that blend conventional pharmacology with botanical synergies is changing how clinicians and consumers evaluate efficacy and risk.

Through a lens of stakeholder alignment, the section contextualizes how regulators, payers, and practitioners are increasingly focused on standardized quality, reproducible dosing, and transparent supply chains. It also outlines the evolving expectations of discerning consumers who demand sustainability credentials and verifiable efficacy data. Taken together, these forces create both opportunity and complexity for organizations seeking to scale responsibly in this rapidly evolving sector.

A synthesis of structural innovations, regulatory tightening, and digital acceleration that are fundamentally reshaping product development, sourcing, and commercialization dynamics

The past five years have seen transformative shifts that are remapping the herbal medicine landscape from production to patient outcomes. Advances in analytical chemistry and genomics have improved species identification and adulteration detection, enabling manufacturers to deliver more consistent and predictable products. Simultaneously, the growth of digital health platforms and telemedicine has lowered barriers to information and distribution, accelerating direct-to-consumer channels while elevating expectations for clinical evidence and safety data.

Regulatory ecosystems are adapting in parallel, with authorities emphasizing good manufacturing practices, provenance documentation, and adverse-event reporting. This regulatory tightening-coupled with consumer demand for sustainability-has driven investments in traceable supply chains, responsible harvesting, and supplier partnerships that prioritize long-term resource stewardship. Innovation in dosing formats and delivery systems, ranging from microencapsulated extracts to transdermal gels, is reshaping product development priorities and opening new therapeutic niches.

At the same time, commercialization is increasingly collaborative: contract manufacturing and ingredient-specialist firms are partnering with brand owners to accelerate time-to-market while enabling smaller innovators to scale. These shifts reflect a broader industry maturation where scientific rigour, digital reach, and supply chain integrity jointly determine competitive differentiation and long-term viability.

A pragmatic analysis of how 2025 United States tariff measures have catalyzed sourcing diversification, operational resilience, and regulatory-compliance investments across the value chain

The introduction of new tariffs by the United States in 2025 has had a multifaceted effect on botanical supply chains, procurement strategies, and commercial positioning across the herbal medicine sector. Import duties on certain botanical inputs and finished formulations have prompted a re-evaluation of supplier portfolios, encouraging procurement teams to diversify sourcing geographies and to build closer direct-supplier relationships that reduce exposure to single-origin risk. As firms adapt, many are prioritizing suppliers with strong traceability systems and vertically integrated capabilities to mitigate tariff-driven volatility.

Tariff pressure has also influenced formulation and packaging choices, with product developers seeking to optimize input lists and packaging footprints to limit cross-border cost exposure. Manufacturers facing higher landed costs have responded through a combination of operational efficiency programs, changed logistics routing, and selective cost pass-through to trade partners. For some brands, this has meant compressing promotional cycles and re-prioritizing channel investments toward higher-margin direct channels where pricing elasticity can be better managed.

Beyond immediate commercial adjustments, tariffs have accelerated strategic conversations about onshoring critical production steps, investing in regional manufacturing capacity, and deepening supplier development programs in lower-tariff jurisdictions. These adaptations are prompting a shift from transactional sourcing toward supplier ecosystem development, where long-term partnerships, technical collaboration, and shared investments in quality assurance become integral to resilience. At the same time, compliance teams are investing more in trade classification expertise and origin verification to ensure tariff treatments are properly applied, thereby reducing unexpected cost leakage and reputational risk.

Integrated segmentation insights that connect product form, botanical origin, product type, therapeutic indication, and channel dynamics to strategic portfolio decisions

Segmentation provides the strategic lens through which product strategies, R&D focus, and channel investments are prioritized. Based on form, stakeholders are rethinking how consumers prefer to receive herbal benefits, with Creams & Ointments, Essential Oils, Liquid Extracts, Powders, Syrups, Tablets & Capsules, and Teas & Infusions each presenting distinct formulation, stability, and compliance considerations that influence manufacturing and shelf-life strategies. Parallel to form choices, botanical origin is a decisive factor: Bark, Flowers, Fruits & Seeds, Leaves, and Roots vary in active constituent profiles, harvest cycles, and sustainability constraints; botanical selection therefore determines not only therapeutic intent but also supply risk and traceability requirements.

Type-based segmentation differentiates product positioning and commercialization routes. Herbal Beauty Products and Cosmetics demand high sensory quality and regulatory labeling that aligns with cosmetic standards, while Herbal Dietary Supplements and Herbal Functional Foods straddle nutrition and health positioning with an emphasis on consumer trust and scientific substantiation. Herbal Pharmaceutical Products require a higher threshold of clinical evidence and regulatory compliance, influencing development timelines and distribution partnerships. Indication-driven segmentation-spanning Cardiovascular Health, Digestive Disorders, General Wellness & Immunity Boosting, Liver & Kidney Disorders, Mental Health, Respiratory Conditions, Sexual Health & Reproductive Issues, and Skin Disorders-guides R&D prioritization and claims strategy, with some indications more amenable to evidence generation than others.

Distribution channels shape access and brand experience. Ayurvedic Clinics & Traditional Healers offer clinical credibility and culturally embedded trust; Direct Selling leverages personal networks and experiential marketing; Health & Wellness Stores and Hospital & Retail Pharmacies provide curated, clinical-facing touchpoints; Online Pharmacies / E-commerce enable scale and data-driven targeting; while Supermarkets / Hypermarkets deliver broad visibility and convenience. Understanding how these segments interact-how a particular form sourced from specific botanical origins aligns with regulatory expectations for a given indication and channel-enables portfolio optimization that is both commercially viable and compliant.

Comparative regional analysis highlighting the Americas, Europe Middle East & Africa, and Asia-Pacific strengths, regulatory variations, and supply chain implications for herbal products

Regional dynamics exert a powerful influence on supply chains, regulatory approaches, and consumer preferences across the herbal medicine ecosystem. In the Americas, established retail infrastructures and growing consumer interest in evidence-based natural health solutions create fertile conditions for premiumized formulations and clinically oriented supplements, while domestic cultivation and processing initiatives seek to reduce import dependency and improve provenance transparency. Cross-border trade agreements and tariff regimes further shape sourcing strategies, with companies balancing costs against access to specific botanical species.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory stringency, cultural acceptance of traditional medicine, and varying levels of manufacturing capacity demand nuanced market entry approaches. In parts of Europe, strong regulatory oversight and consumer protection frameworks necessitate rigorous quality systems and clear claims substantiation, whereas regions with entrenched traditional medicine practices provide alternative channels and partnership models with traditional healers and community practitioners.

The Asia-Pacific region remains a critical supplier and innovation hub, combining rich botanical biodiversity with deep traditional knowledge systems and significant manufacturing scale. Local consumer familiarity with herbal modalities supports rapid product adoption, while investments in standardized extraction technologies and GMP-compliant facilities are elevating export readiness. Across these regions, comparative strengths-ranging from raw material endowments to regulatory sophistication-inform strategic decisions about production location, R&D collaboration, and channel prioritization.

Insightful appraisal of competitive dynamics showing how ingredient specialists, contract manufacturers, digital-native brands, and practitioner networks are shaping consolidation and differentiation

The competitive landscape comprises diverse players with complementary capabilities, ranging from ingredient specialists and contract manufacturers to digitally native brands and practitioner-led enterprises. Ingredient suppliers that provide validated extracts and quality control services have become strategic partners for brands seeking to accelerate formulation timelines while ensuring consistent active profiles. Contract manufacturers and private-label partners enable scale for emerging brands, allowing them to focus resources on marketing, claims substantiation, and channel development.

Digital-first consumer brands are differentiating through direct engagement, data-driven personalization, and agile product launches, often using subscription models to enhance lifetime value. Traditional practitioners and clinic networks remain influential in segments where cultural trust and in-person diagnosis are important, creating hybrid commercialization models that blend clinical validation with community endorsement. Across the industry, there is growing evidence of strategic alliances and M&A activity aimed at consolidating supply chains, acquiring technical capabilities, and expanding geographic reach.

Quality assurance and regulatory compliance functions are increasingly central to competitive positioning. Firms investing in traceability, third-party testing, and transparent labeling are gaining credibility among both consumers and institutional buyers. At the same time, partnerships between science-led organizations and herbal experts are enabling more robust clinical programs that enhance product legitimacy and broaden acceptance within conventional healthcare pathways.

Action-oriented strategic priorities for executives to strengthen supplier ecosystems, accelerate evidence programs, optimize channels, and enhance manufacturing agility

Industry leaders should pursue a clear set of prioritized actions that balance commercial agility with long-term resilience. First, build supplier ecosystems that emphasize diversity, traceability, and co-investment in quality assurance rather than relying on single-source procurement models. Strengthening on-the-ground partnerships in sourcing regions and investing in supplier capacity development will reduce exposure to tariff and climate-related shocks while improving sustainability credentials.

Second, accelerate evidence-generation programs that align with target indications and distribution channels. For consumer-facing wellness products, pragmatic real-world evidence and validated biomarkers can support credible positioning, while for pharmaceutical-grade products, more rigorous clinical pathways should be pursued. Third, optimize channel mix by reallocating investment toward high-value touchpoints; direct channels and clinician-mediated distribution can offer better margin control and data capture, enabling more targeted product iterations.

Fourth, enhance operational flexibility through geographic manufacturing diversification and modular production capabilities that allow rapid reconfiguration in response to trade or regulatory shifts. Finally, embed regulatory and trade-classification expertise into commercial planning to anticipate cross-border cost exposure and to exploit preferential trade arrangements where available. Taken together, these steps create a cohesive approach to mitigate near-term shocks and to build durable competitive advantage.

A rigorous mixed-methods research framework combining primary interviews, documentary analysis, supply chain tracing, and expert validation to ensure credible and actionable findings

The research approach combines mixed-methods techniques designed to ensure validity, credibility, and practical applicability. Primary research included structured interviews and in-depth discussions with a diverse set of stakeholders such as product developers, supply-chain managers, regulatory affairs specialists, clinical practitioners, and channel partners. These conversations were complemented by site-level reviews and virtual facility audits to assess cultivation practices, processing capabilities, and quality-control procedures.

Secondary research synthesized regulatory documents, peer-reviewed literature, and technical standards to construct a detailed picture of compliance expectations and evolving best practices. Supply chain tracing used origin verification tools and certificate review to evaluate provenance and to identify concentration risks. Qualitative synthesis methods were applied to reconcile differing stakeholder perspectives and to surface actionable themes, while internal triangulation against documentary evidence ensured consistency and reduced bias.

Throughout the process, emphasis was placed on transparency: methodology appendices document interview protocols, selection criteria, and validation steps. Findings were iteratively reviewed with subject-matter experts to ensure technical accuracy and to validate implications for strategy and operations. This multi-layered approach supports conclusions that are both evidence-based and directly usable by commercial and technical decision-makers.

A concise synthesis of risk, resilience, and opportunity showing how scientific validation, traceability, and responsible commercialization will determine future winners

The evolving herbal medicine sector presents a blend of opportunity and responsibility. Advances in analytical and clinical methodologies, combined with digital distribution and heightened regulatory expectations, are elevating standards across the value chain. Organizations that invest in transparent supply chains, robust quality systems, and credible evidence generation will be best positioned to capitalize on shifting consumer preferences and tighter regulatory scrutiny.

Resilience will depend on strategic diversification of sourcing, selective onshoring or regional capacity development, and the ability to rapidly reconfigure operations in response to trade or environmental disruptions. Equally important is the cultivation of trust through transparent communication, third-party verification, and targeted clinical programs that substantiate claims while protecting consumer safety. For leaders, the imperative is to align commercial ambitions with sustainable procurement and scientific rigor, thereby ensuring long-term brand integrity and regulatory compliance.

In sum, the sector is moving from fragmentation toward professionalization, where scientific validation, supply chain integrity, and responsible commercialization jointly determine which products and companies will scale successfully in the coming years.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of traditional Chinese herbal formulas into mainstream wellness products
  • 5.2. Rise of personalized herbal supplement regimens driven by genomic and microbiome insights
  • 5.3. Adoption of sustainable wildcrafting and regenerative farming practices for medicinal botanicals
  • 5.4. Expansion of telehealth platforms providing virtual consultation and herbal prescription services
  • 5.5. Development of nanoemulsion and liposomal delivery systems to enhance herbal compound bioavailability
  • 5.6. Collaboration between pharmaceutical and nutraceutical companies to standardize herbal extract quality metrics
  • 5.7. Surge in popularity of adaptogenic mushroom blends for stress management and immune support in wellness routines

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Herbal Medicine Market, by Form

  • 8.1. Creams & Ointments
  • 8.2. Essential Oils
  • 8.3. Liquid Extracts
  • 8.4. Powders
  • 8.5. Syrups
  • 8.6. Tablets & Capsules
  • 8.7. Teas & Infusions

9. Herbal Medicine Market, by Botanical Origin

  • 9.1. Bark
  • 9.2. Flowers
  • 9.3. Fruits & Seeds
  • 9.4. Leaves
  • 9.5. Roots

10. Herbal Medicine Market, by Type

  • 10.1. Herbal Beauty Products / Cosmetics
  • 10.2. Herbal Dietary Supplements
  • 10.3. Herbal Functional Foods
  • 10.4. Herbal Pharmaceutical Products

11. Herbal Medicine Market, by Indication

  • 11.1. Cardiovascular Health
  • 11.2. Digestive Disorders
  • 11.3. General Wellness & Immunity Boosting
  • 11.4. Liver & Kidney Disorders
  • 11.5. Mental Health
  • 11.6. Respiratory Conditions
  • 11.7. Sexual Health & Reproductive Issues
  • 11.8. Skin Disorders

12. Herbal Medicine Market, by Distribution Channel

  • 12.1. Ayurvedic Clinics & Traditional Healers
  • 12.2. Direct Selling
  • 12.3. Health & Wellness Stores
  • 12.4. Hospital & Retail Pharmacies
  • 12.5. Online Pharmacies / E-commerce
  • 12.6. Supermarkets / Hypermarkets

13. Herbal Medicine Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Herbal Medicine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Herbal Medicine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Ayush Herbs herbal products Company
    • 16.3.2. Baidyanath Ayurved
    • 16.3.3. Bionorica SE
    • 16.3.4. Blackmores Limited
    • 16.3.5. Cultivator Natural Products Pvt. Ltd.
    • 16.3.6. DABUR Limited
    • 16.3.7. Emami Limited
    • 16.3.8. Gaia Herbs, Inc.
    • 16.3.9. Herbal Hills
    • 16.3.10. Himalaya Global Holdings Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERBAL MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HERBAL MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HERBAL MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HERBAL MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HERBAL MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HERBAL MEDICINE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TEAS & INFUSIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BEAUTY PRODUCTS / COSMETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GENERAL WELLNESS & IMMUNITY BOOSTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIVER & KIDNEY DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY CONDITIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SEXUAL HEALTH & REPRODUCTIVE ISSUES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDIC CLINICS & TRADITIONAL HEALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SELLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HEALTH & WELLNESS STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HOSPITAL & RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE PHARMACIES / E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. GCC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GCC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GCC HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 310. GCC HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 311. GCC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 312. GCC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 313. GCC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. GCC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. GCC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 316. GCC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 317. GCC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. GCC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. BRICS HERBAL MEDICINE MARKET SIZE,